Showing results (131-140 of 193) with videos related to
Sort By:
Pageof 20
HIV Medicine|July 16, 2008
Recovery of fat following a switch to nucleoside reverse transcriptase inhibitor-sparing therapy in patients with lipoatrophy: results from the 96-week randomized ANRS 108 NoNuke TrialM A Valantin, E Lanoy, M Bentata, et al.Blood|March 27, 2001
Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disordersM Q Du, H Liu, T C Diss, et al.HIV Medicine|January 22, 2003
P-glycoprotein in blood CD4 cells of HIV-1-infected patients treated with protease inhibitorsP Bossi, O Legrand, A-M Faussat, et al.Antimicrobial Agents and Chemotherapy|December 5, 2012
HIV-1 dynamics and coreceptor usage in Maraviroc-treated patients with ongoing replicationP Recordon-Pinson, S Raymond, P Bellecave, et al.The Journal of Antimicrobial Chemotherapy|February 29, 2012
Resistance profiles of emtricitabine and lamivudine in tenofovir-containing regimensA G Marcelin, C Charpentier, M Wirden, et al.Dermatology (Basel, Switzerland)|August 20, 2010
Autoimmune bullous skin diseases occurring under anti-tumor necrosis factor therapy: two case reportsL Boussemart, S Jacobelli, F Batteux, et al.Oncogene|September 7, 2010
Remodeling of VE-cadherin junctions by the human herpes virus 8 G-protein coupled receptorJ Dwyer, A Le Guelte, E M Galan Moya, et al.Lancet (London, England)|September 12, 2001
Safety and efficacy of adefovir dipivoxil in patients co-infected with HIV-1 and lamivudine-resistant hepatitis B virus: an open-label pilot studyY Benhamou, M Bochet, V Thibault, et al.Presse Medicale (Paris, France : 1983)|March 27, 1999
[Immunologic reconstruction after antiretroviral treatment]R Tubiana, G Carcelain, H A Mohand, et al.European Journal of Neurology|October 26, 1999
Plasma and cerebrospinal fluid human immunodeficiency virus type-1 (HIV-1) RNA levels in HIV-related cognitive impairmentB Stankoff, V Calvez, S Suarez, et al.Pageof 20